A group of researchers at Harvard Medical School has developed a strongly cationic nanoparticle that physically absorbs proteins to form a new type of drug-carrier complex in aqueous solution.
Emisphere has entered into a research agreement with Syracuse University, which will combine their respective oral drug delivery technologies to enhance absorption of an appetite-suppressing hormone.
Buccal drug delivery specialist Generex Biotechnology reports that
the production of its chewing gum-based metformin, MetControl, has
been completed ahead of forthcoming trials in patients with
diabetes.
US company Digestive Care (DCI) is quadrupling its manufacturing,
research and development capacity following an increase in demand
for its drug Pancrecarb (pancrelipase).
Canadian contract manufacturer Patheon has teamed up with specialty
pharmaceutical firm Depomed to offer its clients a controlled
release formulation which can grant their drugs increased
bioavailability and less frequent dosing.
Merrion Pharmaceuticals has been granted a US patent for a drug
delivery technology that improves the transport of medicines across
biological membranes.
Israeli drug company Intec Pharma has published a results of a
clinical trial showing that its drug delivery platform can extend
the release of an active ingredient in the upper gastrointestinal
tract for more than six hours and double...
West Pharmaceutical Services of the US said yesterday that it is
looking to hive off its drug delivery business and focus on its
primary business in prefilled syringes and components.
A new drug delivery company, Merrion Pharmaceuticals, has been set
up to commercialise various technologies originally developed at
Ireland's Elan, which sold off many of its assets after growing too
quickly throughout the 1990s.
CIMA is granted a US patent covering the use of effervescence to
improve the absorption of poorly-soluble drugs and target delivery
to specific areas of the GI tract.
The Netherlands-based organisation for Applied Scientific Research
(TNO) has signed an agreement with GlaxoSmithKline to collaborate
in the development and use of TNO's in vitro models of the
human gastrointestinal (or "GI")...